Trans-Middle-Ear Mucosal Gas Exchange Project 1, Specific Aim 1

NCT01925482 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Middle Ear Gas Exchange

Interventions

DRUG: 6%CO2, 25%O2, balance N2
DRUG: 6% CO2, 0%O2, balance N2
DRUG: 20%CO2, 6%O2, balance N2
DRUG: 0%CO2, 6%O2, balance N2
DRUG: 6% CO2, 6%O2, balance N2
DRUG: 6%CO2, 6%O2, 0%N2, balance argon

Sponsor

Cuneyt M. Alper

Collaborators

[object Object]